IFNG and lung cancer: For example, it has been reported that CD4+ T cells downregulate IFN-y after activation in lung cancer (we used the hamster lung cancer cell line HT100) through hypermethylation of the IFNG promoter (mechanism of tumour mediated immune suppression) (60).